Pilot Study: The Effect of Ergocalciferol on Plasma Mucin-1 Levels
Status:
Completed
Trial end date:
2020-01-27
Target enrollment:
Participant gender:
Summary
To determine if a one-time oral administration of ergocalciferol results in a decline in
plasma mucin-1 levels in healthy individuals and individuals with ADTKD-MUC1.